The cost-effectiveness of pharmacist-led treatment of cardiac risk in patients with type 2 diabetes.

The cost-effectiveness of pharmacist-led treatment of cardiac risk in patients with type 2 diabetes. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The cost-effectiveness of pharmacist-led treatment of cardiac risk in patients with type 2 diabetes. Abstract Text:

Andrew Lowey,Sara Moore,Catherine Norris,David Wright,Jonathan Silcock,Peter Hammond,Andrew Lowey,Sara Moore,Catherine Norris,David Wright,Jonathan Silcock,Peter Hammond,

AIM: People with type 2 diabetes mellitus have an increased risk of cardiovascular and cerebrovascular disease compared with the general population. Following attempts to change lifestyle, pharmacological treatment is necessary to modify this risk. However, the use of medicines may be sub-optimal because of infrequent or inadequate medication review. SETTING: Harrogate District Hospital, a medium-sized district general hospital in a rural area of North Yorkshire, England. METHOD: A pharmacist-led hospital clinic was established to manage diabetic patients suffering from resistant hypertension with or without hyperlipidaemia. Patients with two consecutive elevated blood pressure (BP) readings (>140/80 mmHg) were recruited via referral from out-patient clinics and diabetic nurse specialists. A range of clinical indicators were assessed on referral. The pharmacist prepared individualised patient information and a patient-held record card. An evidence-based algorithm was used to make adjustments (every 4 weeks) to anti-hypertensive medication. If necessary treatment of hyperlipidaemia was also optimised. Published data was used to predict the 10-year risk of coronary heart disease and cerebrovascular accident for each patient before and after intensive medicines management. Patients were discharged from the clinic after two consecutive target BP measurements. RESULTS: It is estimated that these risks were reduced by 11.9 and 9.6%, respectively, at a cost per event avoided of pound 34,708 and pound 63,320. CONCLUSION: Intensive pharmacist-led clinics are potentially a cost-effective way to improve the cardiovascular health of patients with type 2 diabetes.

The cost-effectiveness of pharmacist-led treatment of cardiac risk in patients with type 2 diabetes. Publishing Authors By Initials

A Lowey,S Moore,C Norris,D Wright,J Silcock,P Hammond,A Lowey,S Moore,C Norris,D Wright,J Silcock,P Hammond,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

The cost-effectiveness of pharmacist-led treatment of cardiac risk in patients with type 2 diabetes. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Pharmacy world & science : PWS

VOLUME: 29

Page Numbers: 541-5

Journal Abbreviation:

ISSN: 0928-1231

DAY: 30

MONTH: 03

YEAR: 2007

The cost-effectiveness of pharmacist-led treatment of cardiac risk in patients with type 2 diabetes. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9307352

The cost-effectiveness of pharmacist-led treatment of cardiac risk in patients with type 2 diabetes. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: The cost-effectiveness of pharmacist-led treatment of cardiac risk in patients with type 2 diabetes. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for The cost-effectiveness of pharmacist-led treatment of cardiac risk in patients with type 2 diabetes.

AFFILIATION: Pharmacy Department, Gledhow Wing, Leeds TeachingHospitals NHS Trust, St. James University Hospital, Beckett Street, Leeds, LS9 7TF, UK. andrew.lowey@leedsth.nhs.uk

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Pharm World Sci

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The cost-effectiveness of pharmacist-led treatment of cardiac risk in patients with type 2 diabetes Related Publications

• A classification of handedness using the Annett Hand Preference Questionnaire.
• Adenylyl cyclase gene transfer in heart failure.
• Adenylylcyclase gene transfer increases function of the failing heart.
• Androstene-3,5-dienes as ER-beta selective SERMs.
• Axial patterning in the developing vertebrate inner ear.
• Cell-based GATA4 cardiac gene transfer using cell-penetrating peptide.
• Combined oral contraceptives: a comprehensive review.
• Diamagnetic levitation changes growth, cell cycle, and gene expression of Saccharomyces cerevisiae.
• Editorial--Individuation through socialization.
• Effect of burn injury on corticosteroid-binding globulin levels in plasma and wound fluid.
• Food at end of life.
• Intramolecular hydroamination of difluoropropargyl amides: regioselective synthesis of fluorinated beta- and gamma-lactams.
• Large scale synthesis of the Cdc42 inhibitor secramine A and its inhibition of cell spreading.
• Mechanisms responsible for the enhanced antinociceptive effects of micro-opioid receptor agonists in the rostral ventromedial medulla of male rats with persistent inflammatory pain.
• MicroRNAs as tumor suppressors.
• Microarray Analysis of miRNA Gene Expression.
• New signaling pathways associated with increased cardiac adenylyl cyclase 6 expression: implications for possible congestive heart failure therapy.
• Ovarian mucinous tumour arising in mature cystic teratoma and associated with pseudomyxoma peritonei: report of two cases and comparison with ovarian involvement by low-grade appendiceal mucinous tumour.
• Promoting the peer-related social development of young children with mild developmental delays: effectiveness of a comprehensive intervention.
• Selective synthesis of fluorinated furan derivatives via AgNO3-catalyzed activation of an electronically deficient triple bond.
• Sex hormone-binding globulin expression in sea bass (Dicentrarchus labrax L.) throughout development and the reproductive season.
• Suitability of the retrograde tracer Dil for electrophysiological studies of brainstem neurons: adverse ramifications for G-protein coupled receptor agonists.
• Testicular, semen and blood parameters in adapted and nonadapted Bos taurus bulls in the semi-arid tropics.
• The Bead blot: a method for selecting small molecule ligands for protein capture and purification.
• The TATA binding protein associated factor 4b (TAF4b) mediates FSH stimulation of the IGFBP-3 promoter in cultured porcine ovarian granulosa cells.
• The cost-effectiveness of pharmacist-led treatment of cardiac risk in patients with type 2 diabetes.
• The glare hypothesis of macular pigment function.
• Therans-3-enoic acids ofAster alpinus andArctium minus seed oils.
• Three-dimensional face shape in Fabry disease.
• microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder.